Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIG Regulatory News (SHI)

Share Price Information for SIG (SHI)

Share Price is delayed by 15 minutes
Get Live Data
8.55    0.40 (4.91%)
Bid:
7.74
Ask:
8.09
Spread: 0.35 (4.522%)
Market Cap: £98.82m
SHI Live PriceLast checked at - London Stock Exchange

Intraday SIG Share Chart

Directorate Changes

8 Mar 2023 07:01

RNS Number : 2200S
SIG PLC
08 March 2023
Β 

LEI: 213800VDC1BKJEZ8PV53 8 March 2023

Β 

SIG plc (the "Company" or "SIG")

Directorate changes

SIG announces that Christian Rochat, one of the two Directors appointed by CD&R Sunshine S.Γ€ R.L ("CD&R"), informed the Company yesterday that he does not intend to stand for re-election at the Annual General Meeting on 4 May 2023 (the "AGM"). CD&R yesterday served notice on the Company that it intends to nominate Mr Diego Straziota for appointment to SIG's Board at the AGM.

Β 

Mr Straziota is a Managing Director at CD&R principally engaged in evaluating investment opportunities in the industrials and business services verticals. He has served as CD&R's appointed observer to SIG's Audit & Risk Committee since July 2020. There are no disclosures required in respect of this appointment pursuant to Listing Rule 9.6.13 (1) to (6).

Β 

Commenting on these changes, SIG's Chairman Andrew Allner said "Christian joined the Board at the time of CD&R's investment in July 2020. We are grateful to him for the contribution he has made to the Company's turnaround and progress since then, to the benefit of all of SIG's shareholders. Diego is well-known to the Board, and we look forward to working with him."

Β 

Β 

SIG plc

Β 

+44 (0) 114 285 6300

Andrew Allner

Chairman

FTI Consulting

Β 

+44 (0) 20 3727 1340

Richard Mountain

Peel Hunt LLP - Joint broker to SIG

+44 (0) 20 7418 8900

Mike Bell / Charles Batten

Β 

Β 

Investec Bank plc - Joint broker to SIG

+44 (0) 20 7597 5970

Bruce Garrow / David Anderson

Β 

Notes

Β· There are no remuneration payments (within the meaning of section 430(2B) of the Companies Act 2006) that will be paid to Christian Rochat following him ceasing to be a director and he will not receive any payment for loss of office

Β 

Β· Under the terms of the relationship agreement dated 29 May 2020 between the Company and CD&R, whilst CD&R holds at least 20% of the votes able to be cast at general meetings of the Company, CD&R has the right to appoint two non-executive directors to the Board (each a "Nominee Director"). In addition, whilst CD&R holds at least 10% of the votes able to be cast at general meetings of the Company, CD&R has the right to designate a Nominee Director to sit on each of the Remuneration Committee and the Nominations Committee, and to appoint an observer to the Audit & Risk Committee

Β 

Β· Christian Rochat is a member of the Nominations Committee. Upon him ceasing to be a director, CD&R's other current Nominee Director, Bruno Deschamps, shall be appointed a member of the Nominations Committee. Bruno will remain a member of the Remuneration Committee

Β 

Β· Diego Straziota shall continue to be CD&R's appointed observer to the Audit & Risk Committee following his appointment as a Nominee Director

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOADDGDXUGGDGXR
Date   Source Headline
3rd Jun 20263:50 pmRNSDirector/PDMR Shareholding
28th May 20262:56 pmRNSDirector/PDMR Shareholding
22nd May 20261:36 pmRNSDirector/PDMR Shareholding
22nd May 20261:29 pmRNSDirector/PDMR Shareholding
22nd May 20261:18 pmRNSResult of Meeting
20th May 20263:07 pmRNSDirector/PDMR Shareholding
14th May 20264:44 pmRNSDirector/PDMR Shareholding
13th May 20265:27 pmRNSDirector/PDMR Shareholding
6th May 202611:11 amRNSDirector/PDMR Shareholding
6th May 202610:24 amRNSNotice of GM
30th Apr 20262:00 pmRNSResult of AGM
30th Apr 20267:01 amRNSTrading Update
30th Apr 20267:00 amRNSAppointment of Chief Financial Officer
10th Apr 20267:00 amRNSDirectorate change
23rd Mar 202610:57 amRNSDirector/PDMR Shareholding
23rd Mar 20269:59 amRNSNotice of AGM
4th Mar 202610:18 amRNSAnnual Financial Report
4th Mar 20267:00 amRNSFull year results for year ended 31 December 2025
15th Jan 20264:02 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNS2025 Full Year Trading Update & Strategy Framework
19th Dec 20257:00 amRNSNotice of Trading & Business Update
19th Dec 20257:00 amRNSNotice of Trading & Business Update
23rd Oct 202511:05 amRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSQ3 Trading Update
1st Oct 20259:00 amRNSDirector/PDMR Shareholding
3rd Sep 202510:54 amRNSHolding(s) in Company
28th Aug 20251:02 pmRNSResult of Meeting
8th Aug 202511:01 amRNSNotice of GM
5th Aug 20257:00 amRNSResults for the six months to 30 June 2025
8th Jul 20257:01 amRNSAppointment of CEO and Chair designate
8th Jul 20257:00 amRNSH1 Trading Update
9th May 20257:00 amRNSDirectorate Change
6th May 20253:00 pmRNSHolding(s) in Company
1st May 20253:12 pmRNSResult of AGM
30th Apr 20257:00 amRNSTrading Update
10th Apr 20254:02 pmRNSDirector/PDMR Shareholding
4th Apr 202511:10 amRNSDirector/PDMR Shareholding
1st Apr 20254:00 pmRNSHolding(s) in Company
28th Mar 20255:03 pmRNSDirector/PDMR Shareholding
28th Mar 20254:59 pmRNSDirector/PDMR Shareholding
24th Mar 202510:06 amRNSNotice of AGM
21st Mar 20254:44 pmRNSDirector/PDMR Shareholding
12th Mar 20259:06 amRNSDirector/PDMR Shareholding
12th Mar 20258:54 amRNSDirectorate Change
10th Mar 20258:32 amRNSDirector/PDMR Shareholding
5th Mar 202511:17 amRNSAnnual Financial Report
5th Mar 20257:00 amRNSFull year results for year ended 31 December 2024
4th Mar 202512:52 pmRNSHolding(s) in Company
19th Feb 20257:00 amRNSHolding(s) in Company
30th Jan 20255:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.